Innovating Works

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI)

Activa
PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado
CGI-Clinics: Data driven cancer genome interpretation for personalised cancer treatment FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advis...
2022-05-20 - 2027-10-31 | Financiado
RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 HIPRA SCIENTIFIC tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado
SPIOMET4HEALTH: PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY FUNDACIO PRIVADA PER LA RECERCA I LA DOCENCIA SANT JOAN DE DEU tramitó un H2020: H2020-SC1-BHC-2018-2020 Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affectin...
2021-02-01 - 2026-03-31 | Financiado
SmartAge: Gut brain axis Targets for improvement of cognition in the elderly UNIVERSITATSKLINIKUM JENA tramitó un H2020: H2020-MSCA-ITN-2019 In Europe, the population is aging. The age-associated decline in cognitive functions represents a serious social and medical problem. Recen...
2020-06-22 - 2025-02-28 | Financiado
ProCAncer-I: An AI Platform integrating imaging data and models supporting precision care through prostate cance... IDRYMA TECHNOLOGIAS KAI EREVNAS tramitó un H2020: H2020-SC1-FA-DTS-2018-2020 In Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices, of...
2020-05-29 - 2024-09-30 | Financiado
SOPHIA: Stratification of Obesity Phenotypes to Optimize Future Therapy UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN tramitó un H2020: H2020-JTI-IMI2-2019-17-two-stage SOPHIA will optimise the future treatment of obesity. The challenge is that clinicians, payers and patients view obesity as a failure of sel...
2020-05-26 - 2025-05-31 | Financiado
PEPPER: Patient Empowerment through Predictive PERsonalised decision support OXFORD BROOKES UNIVERSITY tramitó un H2020: H2020-PHC-2014-2015 This proposal is for a personalised decision support system for chronic disease management that will make predictions based on real-time dat...
2015-11-10 - 2020-03-31 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe UNIVERSITE GRENOBLE ALPES tramitó un H2020: H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado
WAKE-UP: Efficacy and safety of MRI based thrombolysis in wake up stroke a randomised double blind placebo... UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF tramitó un FP7: WAKE-UP is an investigator-initiated, multicentre, randomised, double-blind, placebo-controlled trial designed to test efficacy and safety o...
Financiado
FLORINASH: The role of intestinal microflora in non alcoholic fatty liver disease NAFLD INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE tramitó un FP7: As worldwide metabolic disease pandemics rise relentlessly with their concomitant clinical complications such as non alcoholic fatty liver d...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.